Sleep Profiler NDD uses artificial intelligence to derive novel sleep biomarkers used to profile neurodegenerative disorder risk including differentiation of Alzheimer’s or Lewy body disease, or normal cogntive aging from mild cognitive impairment. Sleep Profiler NDD also provides automated detectio...
Manufactured by
South Korea
Advanced Brain Monitoring (ABM), founded in 1997 and based in Carlsbad, California, is a pioneering neurotechnology firm revolutionizing brain health diagnostics through non-invasive, EEG-based platforms and systems. The company specializes in portable, FDA-cleared neurodiagnostic systems that assist in early detection and treatment of neurodegenerative, neurological, psychiatric, and sleep-related disorders. With a strong intellectual property portfolio (24 granted patents), ABM’s product suite includes state-of-the-art EEG-based monitoring systems tailored for clinical, research, and clinical trial applications. The company has leveraged AI-driven analytics to provide automated biomarkers, enhancing medical decision-making for Alzheimer’s and Parkinson dementia, PTSD, sleep apnea, insomnia and many more. ABM’s solutions have been widely adopted across clinical, research institutions, and healthcare providers. Its continuous innovation in neurodiagnostics has resulted in 12 FDA-clearances, with 7 currently in active use supporting global patient care and research initiatives. ABM follows an in-house, comprehensive product development process—identifying unmet medical needs and pioneering new market applications—from initial concept and biomarker discover to fully validated products, creating a distinct competitive advantage.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SLOWAVE INC.
South Korea · 3 relevant products
Philips
Brazil · 1 relevant product
HEMEX AG
Switzerland · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
EUROIMMUN
United States · 1 relevant product
neuroClues SRL
Belgium · 1 relevant product
Brainsecrets.co.,Ltd
South Korea · 1 relevant product
OKUMAN MEDIKAL SISTEMLER A.S.
Türkiye · 1 relevant product
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 1 relevant product
AI Platform Co., Ltd.
South Korea · 1 relevant product
3 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 15 closest product alternatives
SLOWAVE INC. · South Korea
Diagnostic tool for pre-sleep neurological assessment measuring brain function, attention deficits, anxiety levels, cognitive load, and sleep-related memory consolidation. Supports baseline neurological evaluation prior to sleep monitoring.
Philips · Brazil
Diagnostic solutions for the identification and assessment of sleep disorders. Enables healthcare providers to diagnose sleep conditions in patients.
SLOWAVE INC. · South Korea
Clinical module for automated sleep stage analysis including identification of N1, N2, N3, and REM sleep phases. Provides quantification of sleep efficiency, total sleep time, and sleep architecture assessment.
HEMEX AG · Switzerland
Digital biomarker diagnostic system for early and moderate-stage Alzheimer's disease detection using advanced brain imaging analysis. Supports early intervention and treatment planning.
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
EUROIMMUN · United States
Diagnostic tests for detection of biomarkers associated with neurodegenerative diseases including Alzheimer's and Parkinson's disease. These tests support early identification and monitoring of neurological decline in patient populations.
neuroClues SRL · Belgium
Non-invasive clinical assessment tool utilizing eye movement biomarkers to aid in diagnosis of neurological diseases. Provides objective measurements for disease progression monitoring and treatment efficacy evaluation with research-grade temporal and spatial resolution.
Brainsecrets.co.,Ltd · South Korea
System for identifying and analyzing neurobiological markers in EEG and physiological data for clinical diagnosis and treatment monitoring.
OKUMAN MEDIKAL SISTEMLER A.S. · Türkiye
Diagnostic systems for sleep disorder assessment and evaluation. Monitors sleep patterns and respiratory events for comprehensive sleep medicine diagnosis.
SLOWAVE INC. · South Korea
Clinical assessment tool for distinguishing sleep-related disorders including sleep onset insomnia, sleep maintenance insomnia, and early morning awakening. Utilizes EEG-based analysis for objective phenotyping.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
A diagnostic test series for early detection of Alzheimer's disease, which is a progressive neurodegenerative disorder of the nervous system and the most common cause of dementia. The series detects key biomarkers including AD7C-NTP, tau protein, and β-amyloid protein, which are associated with the pathological features of Alzheimer's disease such as neurofibrillary tangles and amyloid plaques.
AI Platform Co., Ltd. · South Korea
An artificial intelligence-enabled platform for early detection and ongoing management of dementia. Provides cognitive assessment tools and monitoring capabilities for disease progression tracking.
3 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products